
2.25BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00650F1093
CUSIP
00650F109
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.42
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.39
Wall Street Target Price
20.57
EPS Estimate Current Year
-0.48
EPS Estimate Next Year
-0.27
EPS Estimate Current Quarter
-0.1829
EPS Estimate Next Quarter
-0.182
Most Recent Quarter
-
Revenue TTM
276,976,000
Gross Profit TTM
205,616,992
EBITDA
-39,290,000
Profit Margin
-21.48%
Return On Assets TTM
-6.79%
Return On Equity TTM
-27.82%
Revenue Per Share TTM
1.826
Qtly Revenue Growth YOY
51.00%
Diluted Eps TTM
-0.39
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
8.231
Price Book MRQ
10.4198
Enterprise Value Revenue
7
Enterprise Value EBITDA
0
314.50
7.21%89.96
3.59%806.89
2.97%717.87
2.38%302.81
2.29%135.12
0.69%425.85
0.43%724.55
0.00%269.84
-1.61%22.40
-0.58%